Pharmacogenetics study of telmisartan in hypertension

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002818

Enrollment

Unknown

Registered

2012-12-09

Start date

2006-09-04

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Two groups:telmisartan

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Healthy volunteers: Physical examination are normal, without smoking and drinking history; 2. Hypertension volunteers: systolic blood pressure>140mm Hg, diastolic blood pressure >90mm Hg.

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension; 2. other cardiovascular and cerebrovascular diseases.

Design outcomes

Primary

Measure	Time frame
plasma concentration;	—

Countries

China

Contacts

Public ContactXiao-Ping Chen

chenxp74@hotmail.com+86 13875803018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026